DexCom PE ratio DXCM

Share price divided by earnings per share over the last twelve months, since 2018.

Today, Oct 23, 2026: 30.9×
8-year median: 102×
Against its 8-year history: 4th; percentile: 0 is its lowest day, 100 its highest
8-year range: 26.0× to 343×
Peer median: 24.0×

DexCom's PE ratio is 30.9× as of Oct 23, 2026: a share price of $77.94 against $2.52 of earnings per share over the last twelve months.

That is below its 8-year median of 102×, lower than on 96% of days in the last 8 years.

Over that time it ranged from 26.0× in May 2026 to 343× in Apr 2022.

The median for 9 medical device stocks of a similar size is 24.0×.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	30.9×	26.0×	40.8×
2025	37.7×	30.7×	66.9×
2024	48.3×	39.8×	140×
2023	136×	88.6×	213×
2022	209×	77.6×	343×
2021	101×	64.1×	170×
2020	153×	131×	308×
2019	316×	247×	318×
2018	252×	230×	318×

Against its peers

Companies in Medical - Devices nearest DexCom's size, closest first, today.

Company	PE ratio
DXCMDexCom	30.9×
GEHCGE HealthCare Technologies	16.4×
ZBHZimmer Biomet	24.0×
EWEdwards Lifesciences	51.2×
BSXBoston Scientific	18.5×
SYKStryker	31.8×
MDTMedtronic	23.4×
ABTAbbott Laboratories	38.7×
LIVNLivaNova	23.9×
ITGRInteger	34.6×
Peer median	24.0×

Where DexCom ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on DexCom

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.